Pharmicell (005690) — Cash Flow Quality Index
Pharmicell (005690) has a Cash Flow Quality Index of 1.00x as of September 2025. Operating cash flow of ₩8.78 Billion exceeds net income of ₩8.78 Billion, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Pharmicell to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharmicell Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Pharmicell across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 005690 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Pharmicell (2019–2024)
Year-by-year earnings quality comparison for Pharmicell. For live market cap and the full company financial profile, see market value of Pharmicell.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | ₩3.50 Billion | ₩6.33 Billion | ▼ -83.3% |
| 2023 | 3.30x | ₩11.81 Billion | ₩3.58 Billion | ▲ +244.7% |
| 2022 | 0.96x | ₩7.91 Billion | ₩8.26 Billion | ▲ +273.4% |
| 2021 | -0.55x | ₩-5.22 Billion | ₩9.45 Billion | ▼ -132.3% |
| 2020 | 1.71x | ₩8.98 Billion | ₩5.24 Billion | ▲ +9962.0% |
| 2019 | -0.02x | ₩-75.50 Million | ₩4.35 Billion | — |